SLONIN JONATHAN 4
4 · Pacira BioSciences, Inc. · Filed Jun 7, 2023
Insider Transaction Report
Form 4
SLONIN JONATHAN
Chief Medical Officer
Transactions
- Sale
Common Stock
2023-06-07$37.87/sh−490$18,554→ 36,323 total - Sale
Common Stock
2023-06-06$38.99/sh−471$18,365→ 36,813 total
Footnotes (2)
- [F1]Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
- [F2]Includes 205 shares of common stock acquired under the issuer's employee stock purchase plan in December 2022.